Business Context and Reporting Period
Tower Semiconductor Ltd. (NASDAQ: TSEM) reported unaudited financial results for the three months ended March 31, 2003, in a Form 6-K filed on May 4, 2003. The company operates as a pure-play independent wafer foundry with two facilities: Fab 1 (1.0 to 0.35 microns) and Fab 2 (0.18 microns and below), which is currently under construction and ramp-up.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 | Q4 2002 |
|---|---|---|---|
| Sales | $12.6 million | $8.4 million | $11.6 million (operations only) |
| Gross Loss | $(5.3 million) | $(5.0 million) | Not explicitly stated |
| Operating Loss | $(14.8 million) | $(11.4 million) | Not explicitly stated |
| Net Loss | $(14.4 million) | $(12.0 million) | $(13.6 million) |
| Loss Per Share (Basic) | $(0.33) | $(0.47) | $(0.33) |
| Cash and Equivalents | $12.2 million | $17.0 million (Q1 2002) | $7.9 million (Dec 31, 2002) |
| Total Debt (Short + Long Term) | $286.0 million | Not explicitly stated | $257.0 million |
| Shareholders' Equity | $284.1 million | Not explicitly stated | $298.3 million |
Notes: The Q1 2003 net loss includes approximately $12.6 million in non-capitalized Fab 2 expenses. Sales increased 50% year-over-year and 9% sequentially (excluding a one-time $4.0 million technology agreement revenue in Q4 2002).
Material Changes vs. Prior Period
- Revenue Growth: Sales rose to $12.6 million from $8.4 million in Q1 2002, driven by improved unit sales and higher average selling prices at Fab 1.
- Expense Increase: Operating expenses increased significantly due to $9.5 million in operating costs and expenses, heavily influenced by non-capitalized Fab 2 development costs ($12.6 million total non-capitalized Fab 2 expenses in Q1 2003 vs. $10.8 million in Q4 2002).
- Liquidity: Cash and cash equivalents increased to $12.2 million from $7.9 million at year-end 2002, supported by net cash provided by financing activities of $28.9 million (primarily $30 million in long-term debt proceeds).
- Debt Levels: Long-term debt increased to $282.0 million from $253.0 million at December 31, 2002.
Guidance, Outlook, and Risks
Outlook and Management Commentary:
- Fab 1: Management anticipates modest sales increases in Q2 2003 and expects to continue generating positive operating cash flow from Fab 1 operations.
- Fab 2: The facility is entering commercial 0.18-micron production in Q2 2003 with first volume orders received from two wafer partners. Equipment installation continues to ramp up production.
- Financing: The company is negotiating with banks to amend its credit facility to reflect revised Fab 2 plans and milestone deadlines. It must raise at least $22 million in additional funding for Fab 2 by the end of 2003 to satisfy partner agreements.
Risks and Contingencies:
- Default Risk: Failure to renegotiate the credit facility or meet revised financing milestones could result in an event of default, allowing banks to call loans and exercise liens.
- Regulatory and Partner Approvals: Amendments to investment agreements require shareholder, bank, and Israeli Investment Center approvals.
- Market Conditions: Results are subject to general semiconductor market conditions and the successful ramp-up of Fab 2 production.
Investor Verification Checklist
- Confirm the status of negotiations with banks regarding the amendment of the Fab 2 credit facility and the extension of financing deadlines.
- Verify the timeline and conditions for raising the required $22 million in additional funding for Fab 2 by December 31, 2003.
- Monitor the approval status of the revised Fab 2 business plan by the Israeli Investment Center and the Company's shareholders.
- Assess the impact of non-capitalized Fab 2 expenses on future profitability as the facility transitions to full commercial production.
- Review the company's ability to meet the fifth and sixth milestones for Fab 2 under the revised schedule to avoid default.